Your browser doesn't support javascript.
loading
An overview on nanoparticle-based strategies to fight viral infections with a focus on COVID-19.
Yasamineh, Saman; Kalajahi, Hesam Ghafouri; Yasamineh, Pooneh; Yazdani, Yalda; Gholizadeh, Omid; Tabatabaie, Raheleh; Afkhami, Hamed; Davodabadi, Fatemeh; Farkhad, Alireza Khanalipour; Pahlevan, Daryoush; Firouzi-Amandi, Akram; Nejati-Koshki, Kazem; Dadashpour, Mehdi.
Afiliação
  • Yasamineh S; Young Researchers and Elite Club, Tabriz Branch, Islamic Azad University, Tabriz, Iran.
  • Kalajahi HG; Department of Medical Biotechnology, Institute of Higher Education Rab-Rashid, Tabriz, Iran.
  • Yasamineh P; Department of Biotechnology, Institute of Science, Uskudar University, Istanbul, Turkey.
  • Yazdani Y; Young Researchers and Elite Club, Tabriz Branch, Islamic Azad University, Tabriz, Iran.
  • Gholizadeh O; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Tabatabaie R; Department of Virology, Faculty of Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Afkhami H; Department of Medical Immunology, Faculty of Medical Sciences, Hamadan University, Hamadan, Iran.
  • Davodabadi F; Department of Medical Microbiology, Faculty of Medicine, Shahed University of Medical Science, Tehran, Iran.
  • Farkhad AK; Department of Biology, Faculty of Basic Science, Payame Noor University, Tehran, Iran.
  • Pahlevan D; Young Researchers and Elite Club, Tabriz Branch, Islamic Azad University, Tabriz, Iran.
  • Firouzi-Amandi A; Determinants of Health Research Center, Semnan University of Medical Sciences, Semnan, Iran.
  • Nejati-Koshki K; Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Dadashpour M; Pharmaceutical Sciences Research Center, Ardabil University of Medical Sciences, Ardabil, Iran. k.nejati@arums.ac.ir.
J Nanobiotechnology ; 20(1): 440, 2022 Oct 08.
Article em En | MEDLINE | ID: mdl-36209089

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nanopartículas / Tratamento Farmacológico da COVID-19 Limite: Humans Idioma: En Revista: J Nanobiotechnology Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Irã

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nanopartículas / Tratamento Farmacológico da COVID-19 Limite: Humans Idioma: En Revista: J Nanobiotechnology Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Irã